ISRCTN85255912
Completed
未知
Treatment of high risk testicular tumour with high dose chemotherapy with peripheral blood stem cells
Department of Health (UK)0 sites6 target enrollmentSeptember 12, 2003
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cancer: Testicular
- Sponsor
- Department of Health (UK)
- Enrollment
- 6
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with histological proven non\-seminomatous germ cell tumours
- •2\. High risk factors as defined by MRC prognostic group
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 TrialProstate cancerTherapeutic area: Diseases [C] - Neoplasms [C04]CTIS2022-501551-90-00Gasthuiszusters Antwerpen493
Withdrawn
Not Applicable
Towards optimal treatment for high risk prostate cancer; stereotactic pelvic radiotherapy with focal boost to the primary tumorNL-OMON56376Haaglanden Medisch Centrum228
Active, not recruiting
Not Applicable
TREATMENT OF NON-INVASIVE BLADDER CANCER WITH HIGH RISK OF RECURRENCE – BLUE LIGHT CYSTOSCOPY WITH CHEMOTHERAPYbladder cancer (non-invasive Ta urothelial bladder cancer)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-000559-15-FIFinnBladder
Completed
Not Applicable
Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort StudyBladder CancerNCT02113501Hospital Universitari Vall d'Hebron Research Institute200
Active, not recruiting
Not Applicable
THERApy de-escalation for TESTicular cancerISRCTN61007118Queen Mary University of London30